Company intelligence / Profile preview

Glycominds

Ownership: Private
Development stage: Commercial

Overview

Glycominds develops proprietary biomarker-based diagnostic tests focused on non-invasive detection, prognosis, and therapy monitoring for gastrointestinal diseases such as IBD/Crohn's disease. Its lead product IBDX® offers a validated serum biomarker test that enables early diagnosis and risk stratification. The company also has pipeline programs targeting multiple sclerosis with blood-based diagnostics as well as early detection tools for colorectal/breast cancers using glycan biomarkers.

Therapeutic areas: GastroenterologyOncologyNeurologyWomen's Health
Modalities: Diagnostic reagent/kit (Biologic)Biomarker-based diagnostics (Biologic)Blood test (Device/Biologic)
Industry: Protein Biomarker Diagnostics

Drug pipeline

2 assets

Ulcerative Colitis Response Index

Commercial

Indications: Ulcerative colitis

1 more asset in the full pipeline.

Request access →

Partnerships

Biomolecular Photonic Consortium in Israel to develop molecular imaging techniques with Given Imaging CSO involvement

Beyond the preview

Go deeper on Glycominds.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Glycominds.

Explore the full profile